FTC Charges Drug Manufacturers with Stifling Competition in Two Prescription Drug Markets
Date
The Federal Trade Commission today charged two drug makers, Hoechst Marion Roussel (now Aventis) and Andrx Corporation, with engaging in anticompetitive practices in violation of Section 5 of the FTC...